My thoughts:

As we saw during COVID, it’s very important that we improve our pharmaceutical manufacturing and medical supply chains here in Canada. I also see this as a reason why an extensive national pharmacare plan is important. Countries that have implemented such programs have been able to negotiate better deals for the drugs by acting as a single unit instead of many smaller provincial and private organizations. Instead of cutting healthcare services, we could stop paying unreasonably high prices on pharmaceuticals.

Finally, maybe it’s time that Canada reevaluated some of the IP protections that american pharmaceutical companies get.